We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Biopsy Followed by Immediate Curettage and Electrodesiccation of Suspected Basal Cell Carcinomas at the First Visit FREE

Gary M. White, MD1; Hui Cynthia Zhou, MS, PhD1; Raoul J. Burchette, MS1
[+] Author Affiliations
1Department of Dermatology, Kaiser Permanente, San Diego, California
JAMA Dermatol. 2013;149(8):980-981. doi:10.1001/jamadermatol.2013.727.
Text Size: A A A
Published online

The diagnosis and treatment of basal cell carcinoma (BCC) represents a significant portion of the work for many dermatologists. Any efficiency in this endeavor is welcome. This study assesses the value of both biopsying and treating a suspected BCC on the first visit.

The purpose of this study was to determine both the positive predictive value (PPV) and the success rate (SR) for the biopsy and treatment at the same (first) visit of a lesion suspected of being a BCC. The PPV was the proportion of cases that our algorithm identified as positive for BCC that actually were BCC on histologic analysis. The SR was defined as the proportion of lesions that were treated appropriately (BCC, squamous cell carcinoma [SCC], Bowen disease, or actinic keratosis) out of the total treated with curettage and electrodesiccation (C & D) on the first visit. The entrance criteria were as follows: (1) The lesion was biopsied by a dermatologist in the department of dermatology; (2) the lesion was thought to be a BCC and BCC only (eg, lesions that the medical chart noted as “rule out BCC vs SCC” were excluded); and (3) the lesion was biopsied and treated with C & D at that same (first) visit.

A retrospective medical chart analysis was performed over approximately 1 year from July 2011 to July 2012. Fifteen dermatologists worked in the department during that time. For any given physician, the 3 most recent months of patient data were analyzed in an attempt to fill the study. The goal was to have at least 500 data points (individual biopsies). After 1 cycle through all 15 dermatologists, the study had not been filled, so an additional 3 months of patient data were analyzed for some of the physicians (chosen at random). The total number of data points was 524.

For all lesions that met these entrance criteria, the results of the biopsy were recorded. The positive predictive value for all lesions was determined twice: first, for all lesions for which the pathologic finding was found to be BCC (PPV), and second for all lesions found to be either a BCC, SCC, Bowen disease, or actinic keratosis (SR)—diagnoses for which C & D is appropriate.

This study was approved by the Kaiser Permanente Southern California institutional review board.

A total of 524 individual biopsies by 15 dermatologists were studied. Many patients had multiple lesions. The positive predicted proportion of BCC was 84.0% (95% CI, 80.5%-87.0%) (Table 1). The positive predicted proportion for BCC, SCC, Bowen disease, or actinic keratosis (SR) was 95.8% (95% CI, 93.7%-97.4%) (Table 2). The individual SR for each of the 15 dermatologists was also calculated (data not shown). These individual SRs varied from 86.84% to 100% showing no outliers. No melanomas or Merkel cell cancers were inadvertently treated with C & D in this study. Benign lesions that were inadvertently treated with C & D were as follows: scar, syringoma, inflammation, purpura, inverted follicular keratosis, epidermal inclusion cyst, seborrheic keratosis, fungal folliculitis, acanthosis, comedone, benign nevus, digital mucous cyst, and sebaceous hyperplasia.

Table Graphic Jump LocationTable 1.  Lesions That Were Basal Cell Carcinoma (BCC) Histologically
Table Graphic Jump LocationTable 2.  Successful Curettage and Electrodesiccation

Basal cell carcinoma is the most common cancer. The cost of its diagnosis and treatment represents a large percentage of the budget for departments of dermatology. The biopsy and immediate C & D at the first visit of a lesion suspected to be a BCC has the potential for improving efficiency. There is a risk, however, that nonmalignant lesions will inadvertently be overtreated or that amelanotic melanomas will be treated and prognostic information (eg, depth of melanoma) will be lost. This study did not address histologic patterns (eg, sclerosing BCC, perineural invasion). If a histologic pattern is found that conveys a high risk of recurrence, surgery at the treatment site can always be performed.

In our pilot study, 84% of lesions thought initially to be BCC turned out to be BCC histologically. Furthermore, 95.8% of the time, C & D was the appropriate treatment for the pathologic diagnosis. Note that all health care providers in this study were board-certified dermatologists. These results cannot be generalized to nondermatologists.

In conclusion, this study supports the notion that performing C & D at the first visit of a lesion suspected of being a BCC by a board-certified dermatologist can be an efficient approach, with a high success rate and a low risk of negative outcomes.


Corresponding Author: Gary M. White, MD, Department of Dermatology, Kaiser Permanente, 7060 Clairemont Mesa Blvd, San Diego, CA 92110 (Gary.M.White@kp.org).

Published Online: June 12, 2013. doi:10.1001/jamadermatol.2013.727.

Author Contributions: Dr White had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: White.

Acquisition of data: White.

Analysis and interpretation of data: All authors.

Drafting of the manuscript: White.

Critical revision of the manuscript for important intellectual content: All authors.

Statistical analysis: Zhou, Burchette.

Administrative, technical, and material support: White.

Study supervision: White.

Conflict of Interest Disclosures: None reported.



Table Graphic Jump LocationTable 1.  Lesions That Were Basal Cell Carcinoma (BCC) Histologically
Table Graphic Jump LocationTable 2.  Successful Curettage and Electrodesiccation



Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles